Debbie Bell

Debbie Bell is a seasoned professional in drug safety and pharmacovigilance, currently serving as Senior Director of Drug Safety Operations at Arrowhead Pharmaceuticals since November 2017, and also holding a similar role since May 2015. Prior experience includes serving as Director of Pharmacovigilance at Omeros Corporation and multiple director-level positions at Amgen, where responsibilities encompassed QA oversight, safety data management, and cross-functional team leadership in therapeutic areas such as bone, inflammation, and oncology. Debbie's career commenced as a Registered Nurse in critical care roles at Los Robles. Educational credentials include an MBA in Finance from UCLA and a Bachelor's Degree in Economics from UC San Diego, complemented by a nursing degree from Los Angeles Pierce College.